Details of issuance or disposal
Report on the exercise status of Series 39 Stock Acquisition Rights (with an exercise price adjustment clause) issued through a third-party allotment
7,200,000 shares (new shares)
The lower thin line represents the existing number of shares to which these shares will be added.
6.54% (7,200,000 shares as a percentage of the 110,026,408 shares outstanding as of 31 August 2026. The body does not state this as a dilution rate.)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Report on the exercise status of Series 39 Stock Acquisition Rights (with an exercise price adjustment clause) issued through a third-party allotment |
| Number of shares to be issued or disposed of | 7,200,000 shares (new shares) |
| Intended allottee | EVO FUND (600,000 rights at issuance) |
| Dilution Rate | 6.54% (7,200,000 shares as a percentage of the 110,026,408 shares outstanding as of 31 August 2026. The body does not state this as a dilution rate.) |
| Total number of issued shares | 110,026,408 shares → 117,226,408 shares |
| Exercise price | ¥22.0 or ¥24.0 (exercise price during the period). Details of the adjustment clause and the adjustment floor are Not disclosed |
| Number of Stock Acquisition Rights | 600,000 rights issued in total, 346,120 unexercised as of 31 August 2026, and 274,120 unexercised currently |
| Most recent equity financing | Timing 1 June 2026 / Type Issuance of Series 39 Stock Acquisition Rights (with an exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the fact of the large-scale exercise. No other reason is stated in the body.